Latest Options News

Minbos Resources has launched a prospectus offering nearly 118 million free attaching options to recent Placement investors, aiming to bolster funding for its Cabinda fertilizer plant amid operational and geopolitical challenges in Angola.

Suzerain Investment Holdings has declared its takeover offer for Entertainment Rewards Limited unconditional, now holding a 90.88% stake and urging remaining shareholders to accept before the December 31 deadline.

Miramar Resources has completed its Tranche 1 share placement and secured a further $205,000 commitment from a director for Tranche 2, pending shareholder approval in early 2026.

HomeCo Daily Needs REIT has announced an ordinary unfranked quarterly distribution of AUD 0.0215 per unit for the period ending 31 December 2025, with a Dividend Reinvestment Plan available to investors.

Charter Hall Long WALE REIT has announced an ordinary unfranked quarterly distribution of AUD 0.06375 per security, payable in February 2026, alongside a Dividend Reinvestment Plan offering a 1% discount.

An independent meta-analysis presented at the ASH Annual Meeting reveals Mesoblast’s remestemcel-L achieves superior remission rates and safety outcomes compared to ruxolitinib in treating steroid-refractory acute graft-versus-host disease.

WIN Metals has raised A$5.5 million through a heavily oversubscribed placement to fund drilling and development at its Radio Gold Mine and Butchers Creek projects, aiming to fast-track gold production.

IGO Limited’s subsidiary has confirmed its commitment to Stage 2 of the farm-in at the Bridgetown-Greenbushes Project, pledging $3 million to increase its ownership to 70%. Extensive soil sampling has revealed a significant lithium-tantalum-niobium-cesium anomaly, underpinning the project's promising exploration outlook.

4DMedical has locked in $30.2 million through an underwriting agreement ensuring full exercise of its listed options, lifting its cash reserves to $63.7 million and setting the stage for a pivotal year in commercialising its CT – VQ™ technology.

Skylark Minerals has completed its acquisition of Ricca Resources’ Côte d’Ivoire gold assets, unlocking a substantial resource base and enabling accelerated exploration plans for early 2026.

Rhythm Biosciences has begun commercialising ColoSTAT®, its blood-based colorectal cancer diagnostic test, following an updated ISO15189, 2022 accreditation. The test offers a new option for symptomatic patients where stool-based screening is unsuitable.

EBR Systems has completed the first patient implant in its Totally Leadless CRT (TLC-AU) feasibility study, marking a strategic step toward expanding wireless cardiac resynchronisation therapy for heart failure patients.